VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 229 filers reported holding VIR BIOTECHNOLOGY INC in Q1 2023. The put-call ratio across all filers is 0.67 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,891 | -8.4% | 77,054 | -13.2% | 0.10% | +3.3% |
| Q1 2023 | $2,064 | -8.1% | 88,732 | +0.1% | 0.09% | -14.8% |
| Q4 2022 | $2,245 | -99.9% | 88,680 | -0.3% | 0.11% | +30.1% |
| Q3 2022 | $1,716,000 | -36.6% | 88,921 | -16.3% | 0.08% | -29.7% |
| Q2 2022 | $2,705,000 | -26.8% | 106,217 | -26.1% | 0.12% | -19.2% |
| Q1 2022 | $3,696,000 | -9.2% | 143,717 | +47.9% | 0.15% | +16.8% |
| Q4 2021 | $4,069,000 | +868.8% | 97,143 | +992.0% | 0.12% | +792.9% |
| Q2 2021 | $420,000 | -7.9% | 8,896 | +0.0% | 0.01% | -12.5% |
| Q1 2021 | $456,000 | +46.6% | 8,893 | -23.7% | 0.02% | +45.5% |
| Q4 2020 | $311,000 | -67.3% | 11,661 | -57.9% | 0.01% | -64.5% |
| Q3 2020 | $951,000 | – | 27,694 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,559,142 | $40,100,000 | 21.56% |
| SB INVESTMENT ADVISERS (UK) LTD | 22,216,644 | $571,412,000 | 2.71% |
| Nan Fung Group Holdings Ltd | 210,563 | $5,416,000 | 2.57% |
| Taikang Asset Management (Hong Kong) Co Ltd | 533,332 | $13,717,000 | 2.34% |
| Crawford Lake Capital Management, LLC | 168,200 | $4,326,000 | 1.80% |
| BOULDER HILL CAPITAL MANAGEMENT LP | 126,900 | $3,264,000 | 1.75% |
| Zebra Capital Management LLC | 22,227 | $572,000 | 1.31% |
| Alaska Permanent Fund Corp | 2,300,000 | $59,156,000 | 0.98% |
| CLARK ESTATES INC/NY | 180,000 | $4,630,000 | 0.73% |
| Temasek Holdings (Private) Ltd | 5,602,553 | $144,097,663 | 0.61% |